News Quantified

MOR – morphosys ag - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year [Yahoo! Finance]

MorphoSys: Hold Rating Until The Novartis Deal Closes [Seeking Alpha]

MorphoSys reports Q1 results [Seeking Alpha]

European Stocks Steady as Philips Soars, Deutsche Bank Drops [BNN Bloomberg (Canada)]

MorphoSys AG Reports First Quarter 2024 Financial Results [Yahoo! Finance]

Wells Fargo & Company

Top News Gainers

3/3 MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab 8.5%

10/29 Morphosys ends development of dermatitis treatment, shares fall [Reuters (UK)] 6.9%

5/7 MorphoSys AG Reports First Quarter 2019 Results 6.8%

3/19 MorphoSys AG (MOR) Q4 2019 Earnings Call Transcript [The Motley Fool] 5.8%

10/21 Invitation to MorphoSys Q3 2019 Conference Call on October 30, 2019 5.7%

8/6 MorphoSys Announces Intention to Submit Marketing Authorization Application for Tafasitamab to European Medicines Agency 4.7%

3/2 FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL 4.5%

6/22 MorphoSys Presents Primary Analysis Data from L-MIND Study of Tafasitamab (MOR208) in combination with Lenalidomide in r/r DLBCL at ICML 2019 4.5%

3/18 MorphoSys Presents Results for Fiscal Year 2019 4.3%

8/7 MorphoSys AG (MOR) Q2 2019 Earnings Call Transcript [The Motley Fool] 3.8%

Top News Decliners

1/13 MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab -8.0%

5/12 MorphoSys AG (MPSYF) CEO Simon Moroney on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.4%

6/24 MorphoSys appoints Jean-Paul Kress as new CEO [Seeking Alpha] -5.3%

4/30 Invitation to MorphoSys' First Quarter 2020 Results Conference Call on May 7, 2020 -5.3%

8/12 Morphosys Ag (MPSYF) CEO Simon Moroney on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.8%

11/18 MorphoSys' tafasitamab B-MIND DLBCL study successfully passed futility analysis -4.2%

3/4 MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation -3.8%

5/22 MorphoSys AG Reports Outcome of Annual General Meeting 2019 -3.4%

4/6 MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures -3.2%

11/4 Chinese Biopharma I-Mab Files For U.S. IPO [Seeking Alpha] -3.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day